Tom Daniel

Tom Daniel has more than 20 years of experience leading and building research and development organizations and leading investments in new companies at the forefront of innovative applications of science and healthcare. During the past five years, he served as a Venture Partner at ARCH Venture Partners, following a decade as President of Global Research and Early Development at Celgene Corporation. He previously served in senior leadership roles at AmbRx, Amgen and Immunex. Tom was formerly a director at Juno, Epizyme, Sana, Larimar and Vir. He currently serves as board chair at LocanaBio and Trotana, and is a board director at Gossamer Bio, Vividion, Magenta, Aspen and Mozart. He chairs the Board of Managers of Life Science Cares-San Diego, is a Trustee of Reed College, is a director at Scripps Research and Chair of the Board of Overseers and is a senior advisor to several private biotechnology companies. A nephrologist and former academic investigator, he was previously C.M. Hakim Professor of Medicine and Cell Biology at Vanderbilt University. Dr. Daniel received his M.D. from the University of Texas, Southwestern, trained in molecular genetics at UTSW, and completed his residency in Internal Medicine at Massachusetts General Hospital.